Evidence map›Paper›PMID 27716277›Full record

ArticleJournal of ovarian research2016

Array-CGH diagnosis in ovarian failure: identification of new molecular actors for ovarian physiology.

Sylvie Jaillard, Linda Akloul, Marion Beaumont, Houda Hamdi-Roze, Christele Dubourg, Sylvie Odent, Solène Duros, Nathalie Dejucq-Rainsford, Marc-Antoine Belaud-Rotureau, Célia Ravel

Open access · goldAbstract read
In one paragraph

Article in Journal of ovarian research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
5.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 31 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Alterations in synaptonemal complex coding genes and human infertility.International journal of biological sciences · 2022
    Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Sylvie JaillardCHU Rennes, Service de Cytogénétique et Biologie Cellulaire, F-35033, Rennes, France.
Linda AkloulCHU Rennes, Service de Génétique Clinique, CLAD Ouest, F-35033, Rennes, France.
Marion BeaumontCHU Rennes, Service de Cytogénétique et Biologie Cellulaire, F-35033, Rennes, France.
Houda Hamdi-RozeCHU Rennes, Service de Génétique Moléculaire et Génomique, F-35033, Rennes, France.
Christele DubourgCHU Rennes, Service de Génétique Moléculaire et Génomique, F-35033, Rennes, France.
Sylvie OdentCHU Rennes, Service de Génétique Clinique, CLAD Ouest, F-35033, Rennes, France.
Solène DurosDépartement de Gynécologie Obstétrique et Reproduction Humaine, CHU Rennes, F-35033, Rennes, France.
Nathalie Dejucq-RainsfordINSERM U1085-IRSET, Université de Rennes 1, F-35042, Rennes, France.
Marc-Antoine Belaud-RotureauCHU Rennes, Service de Cytogénétique et Biologie Cellulaire, F-35033, Rennes, France.
Célia RavelINSERM U1085-IRSET, Université de Rennes 1, F-35042, Rennes, France. celia.ravel@chu-rennes.fr.
Centre Hospitalier Universitaire de Rennes · FRInstitut de génétique et de développement de Rennes · FRInstitut de Recherche en Santé, Environnement et Travail · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundOvarian failure (OF) is considered premature if it occurs before the age of 40. This study investigates the genetic aetiology underlying OF in women under the age of 40 years.

methodsWe conducted an experimental prospective study performing all genome microarrays in 60 patients younger than 40 years presenting an OF revealed by a decrease of circulating Anti-Müllerian Hormone (AMH) and leading to an oocyte donation program.

resultsWe identified nine significant copy number variations (CNVs) including candidate genes potentially implicated in reproductive function. These genes are principally involved in cell division and chromosome segregation (SYCE1, CLASP1, CENP-A, CDC16), in ciliary development and/or function (RSPH1, KIF24), are linked with known gonadal genes or expressed in female genital tract (CSMD1, SEMA6D, KIAA1324).

conclusionsOur data strengthen the idea that microarrays should be used in combination with karyotype for aetiological assessment of patients with OF. This analysis may have a therapeutic impact as the identification of new molecular actors for gonadal development or ovarian physiology is useful for the prediction of an ovarian reserve decline and makes possible preventive fertility preservation.

Indexed as

AdultAnti-Mullerian HormoneComparative Genomic HybridizationFemaleFertility PreservationGene Expression RegulationHumansInfertility, FemaleOocyte DonationOvarian DiseasesOvaryAnti-Mullerian HormoneAnti-müllerian hormoneCopy number variationsGenetics of infertilityOvarian failure

Identifiers

PMID27716277
PMCPMC5048446
OpenAlexW2527752108

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.